{"id":"prostaglandins-e2","safety":{"commonSideEffects":[{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"PGE2 is an endogenous eicosanoid that acts through four G-protein coupled EP receptors (EP1–EP4), triggering diverse downstream signaling pathways. Depending on the receptor subtype and tissue context, PGE2 can suppress or enhance inflammatory responses, promote vasodilation, inhibit platelet aggregation, and modulate bone metabolism and immune cell differentiation. Exogenous PGE2 administration aims to harness these pleiotropic effects therapeutically.","oneSentence":"Prostaglandin E2 (PGE2) binds to EP prostanoid receptors on cell surfaces to modulate inflammation, immune responses, and tissue remodeling.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:30:35.249Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Graft-versus-host disease (GVHD) or related immune/inflammatory conditions (Phase 3 status suggests clinical development in this area)"}]},"trialDetails":[{"nctId":"NCT06557733","phase":"PHASE2","title":"An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-08-22","conditions":"Colorectal Carcinoma, Familial Adenomatous Polyposis","enrollment":38},{"nctId":"NCT07429708","phase":"PHASE3","title":"Dexamethasone as ESPB Adjuvant in Lumbar Laminectomy","status":"COMPLETED","sponsor":"Udayana University","startDate":"2025-03-10","conditions":"Laminectomy, Postperative Pain Management, Prostaglandin E2","enrollment":36},{"nctId":"NCT06653881","phase":"NA","title":"Comparison of Conventional and Cu-NiTi Archwires Regarding Clinical Efficiency and Pain Intensity Using Prostaglandin E2 Biomarker During Alignment and Leveling","status":"COMPLETED","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2024-06-14","conditions":"Anterior Teeth Alignment Efficiency, Pain Perception, PGE2 Biomarker and Their Correlation","enrollment":30},{"nctId":"NCT07399483","phase":"NA","title":"Evaluation of the Biomechanical Response of Orthodontic Tooth Movement to Clear Aligner vs Fixed Orthodontic Appliance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mansoura University","startDate":"2025-08-01","conditions":"Orthodontic Tooth Movement, Tooth Movement","enrollment":20},{"nctId":"NCT07338370","phase":"","title":"Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2026-01","conditions":"Neonatal Prematurity, Patent Ductus Arteriosus in Preterm Infants, Prostaglandins","enrollment":34},{"nctId":"NCT02907060","phase":"PHASE3","title":"Mechanical cervicAl ripeninG for Women With PrOlongedPregnancies","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2017-01-27","conditions":"Prolonged Pregnancy","enrollment":1224},{"nctId":"NCT03471858","phase":"NA","title":"Mechanical Dilation of the Cervix in a Scarred Uterus","status":"COMPLETED","sponsor":"Ministry of Health, Singapore","startDate":"2019-08-29","conditions":"Pregnancy Related, Labor Complication, Cesarean Section; Dehiscence","enrollment":44},{"nctId":"NCT06803992","phase":"PHASE4","title":"Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter","status":"RECRUITING","sponsor":"HaEmek Medical Center, Israel","startDate":"2025-04-06","conditions":"Induction of Labor","enrollment":140},{"nctId":"NCT05205330","phase":"PHASE1, PHASE2","title":"Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rottapharm Biotech","startDate":"2021-11-23","conditions":"Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer","enrollment":107},{"nctId":"NCT03758625","phase":"PHASE1","title":"Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure","status":"COMPLETED","sponsor":"Sharon Riddler","startDate":"2019-01-02","conditions":"HIV Infections","enrollment":40},{"nctId":"NCT04344795","phase":"PHASE1","title":"Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors","status":"COMPLETED","sponsor":"Tempest Therapeutics","startDate":"2020-05-06","conditions":"Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer","enrollment":89},{"nctId":"NCT06756620","phase":"","title":"Investigation of the Etiology of Hypertension and Endothelial Damage in Patients With Cytochrome P450 Oxidoreductase Deficiency","status":"COMPLETED","sponsor":"Ozge Bayrak Demirel","startDate":"2024-12-24","conditions":"Cytochrome P450 Oxidoreductase Deficiency, Hypertension, Endothelial Dysfunction","enrollment":51},{"nctId":"NCT00545194","phase":"PHASE3","title":"Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess","status":"WITHDRAWN","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2002-01","conditions":"Cervical Ripening, Labor, Induced","enrollment":""},{"nctId":"NCT05542056","phase":"","title":"Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-09-26","conditions":"Thiazide-induced Hyponatremia (TIH)","enrollment":232},{"nctId":"NCT05774236","phase":"PHASE3","title":"Cook´s Balloon Versus Dinoprostone for Labor Induction of Term Pregnancies With Fetal Growth Restriction","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2023-03-27","conditions":"Fetal Growth Retardation","enrollment":172},{"nctId":"NCT06490601","phase":"PHASE2","title":"Long Term Beta Thalassemia Treatment: Findings From The Extension Period","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","startDate":"2022-04-01","conditions":"Fetal Hemoglobin, Beta-Thalassemia, Hemoglobinopathies","enrollment":30},{"nctId":"NCT06827197","phase":"","title":"Role of Interleukin-1β and Prostaglandin E2 in Prediction and Outcome of Apnea in Neonates","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-05-01","conditions":"Premature Newborns, Premature Newborns With Gestational Age 28 to 33 Weeks","enrollment":100},{"nctId":"NCT05622968","phase":"NA","title":"Outpatient Induction of Labour Using Intracervical Foley Catheter","status":"TERMINATED","sponsor":"Hospital Kemaman","startDate":"2023-01-01","conditions":"Pregnancy Related, Induction of Labor Affected Fetus / Newborn","enrollment":88},{"nctId":"NCT06307678","phase":"NA","title":"Effect of Calcium Silicate Based Root Canal Medicament on Inflammatory Mediators","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2023-07-07","conditions":"Periapical; Infection","enrollment":60},{"nctId":"NCT04747301","phase":"NA","title":"DOuble-BAlloon Versus PROstaglandin E2 for Cervical Ripening in Low Risk Pregnancies","status":"UNKNOWN","sponsor":"Hanoi Obstetrics and Gynecology Hospital","startDate":"2021-08-01","conditions":"Induction of Labor","enrollment":540},{"nctId":"NCT06145685","phase":"NA","title":"Effect of Smoking Cessation on Salivary IL-1β and PGE-2 Levels Following Non-Surgical Periodontal Therapy","status":"COMPLETED","sponsor":"October 6 University","startDate":"2021-01-01","conditions":"Periodontal Diseases, Smoking Cessation","enrollment":40},{"nctId":"NCT04780269","phase":"PHASE4","title":"Foley Catheter Versus PGE2 for Labor Induction at Term: a Pilot Study","status":"SUSPENDED","sponsor":"Guangzhou Women and Children's Medical Center","startDate":"2023-12","conditions":"Labor Induction, Induced Delivery","enrollment":200},{"nctId":"NCT05761418","phase":"PHASE3","title":"Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2018-03-01","conditions":"Myoma;Uterus","enrollment":90},{"nctId":"NCT04930354","phase":"PHASE1","title":"ECP-1014 Treatment for Patients With Solid Tumor Cancers","status":"UNKNOWN","sponsor":"Euclises Pharmaceuticals, Inc.","startDate":"2023-05","conditions":"Solid Tumor","enrollment":29},{"nctId":"NCT05454059","phase":"NA","title":"Salivary C1P and PGE2 Levels in Periodontitis Patients With T2DM and Effect of Non-Surgical Periodontal Treatment","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2020-10-22","conditions":"Periodontitis, Type 2 Diabetes","enrollment":102},{"nctId":"NCT03142035","phase":"NA","title":"Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2017-10-22","conditions":"Endometriosis","enrollment":189},{"nctId":"NCT03825302","phase":"","title":"Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2021-12-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT04373421","phase":"PHASE4","title":"Effect of St. John's Wort and Olive Oils on the Postoperative Complications","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2018-08-15","conditions":"Impacted Third Molar Tooth","enrollment":90},{"nctId":"NCT04500496","phase":"NA","title":"Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"Postmenopausal Bleeding","enrollment":200},{"nctId":"NCT03806231","phase":"PHASE3","title":"A Trial of Cervidil for Outpatient Pre-induction of Cervical Ripening","status":"TERMINATED","sponsor":"Intermountain Health Care, Inc.","startDate":"2019-08-07","conditions":"Induction of Labor Affected Fetus / Newborn","enrollment":8},{"nctId":"NCT03001661","phase":"PHASE3","title":"An RCT of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt","status":"COMPLETED","sponsor":"Birmingham Women's NHS Foundation Trust","startDate":"2017-12-19","conditions":"Induction of Labor Affected Fetus / Newborn","enrollment":674},{"nctId":"NCT02078102","phase":"PHASE2","title":"A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Sherif S. Farag","startDate":"2014-03-11","conditions":"Multiple Myeloma, Non-Hodgkin's Lymphoma","enrollment":38},{"nctId":"NCT04743297","phase":"PHASE4","title":"Propess Versus Prostin for Induction of Labour in Women With Term PROM","status":"UNKNOWN","sponsor":"University Medical Centre Maribor","startDate":"2021-03","conditions":"Premature Rupture of Membranes at Term, Induction of Labour","enrollment":526},{"nctId":"NCT01647776","phase":"","title":"Screening and Risk Factors of Colon Neoplasia","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2012-04-01","conditions":"Colon Cancer","enrollment":3315},{"nctId":"NCT03033264","phase":"NA","title":"Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2017-01-01","conditions":"Induction of Labor","enrollment":164},{"nctId":"NCT04565340","phase":"","title":"Foley vs Propess for Induction of Labor in Women With Term PROM : Mode of Delivery, Maternal and Fetal Outcomes","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2020-03-01","conditions":"Premature Rupture of Membranes at Term, Mode of Delivery","enrollment":188},{"nctId":"NCT04044079","phase":"PHASE4","title":"Vaginal Dinoprostone Versus Vaginal Misoprostol Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-08-20","conditions":"Office Hysteroscopy","enrollment":150},{"nctId":"NCT04505943","phase":"NA","title":"Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":200},{"nctId":"NCT04505917","phase":"NA","title":"Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":200},{"nctId":"NCT04079140","phase":"PHASE4","title":"Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-15","conditions":"IUD Insertion Pain","enrollment":130},{"nctId":"NCT04280874","phase":"PHASE4","title":"Induction of Labor in Term Pregnancies With Unfavourable Cervix","status":"COMPLETED","sponsor":"Clinical Hospital Merkur","startDate":"2018-12-10","conditions":"Induction of Labor Affected Fetus / Newborn, Prostaglandins Causing Adverse Effects in Therapeutic Use","enrollment":212},{"nctId":"NCT03686085","phase":"PHASE3","title":"Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-09-30","conditions":"Intrauterine Device","enrollment":200},{"nctId":"NCT04080336","phase":"PHASE4","title":"Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Nulliparous Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-10","conditions":"IUD Insertion Complication","enrollment":129},{"nctId":"NCT04046302","phase":"PHASE4","title":"Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-08-30","conditions":"IUD Insertion","enrollment":160},{"nctId":"NCT02829333","phase":"NA","title":"The Effect of Anesthetic Technique on VEGF-C and PGE2","status":"COMPLETED","sponsor":"General Hospital of Ningxia Medical University","startDate":"2015-05","conditions":"Uterine Leiomyomas","enrollment":44},{"nctId":"NCT04045548","phase":"PHASE4","title":"Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-08-10","conditions":"Intrauterine Device","enrollment":200},{"nctId":"NCT01499069","phase":"NA","title":"Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-02","conditions":"Overactive Bladder","enrollment":191},{"nctId":"NCT04080349","phase":"PHASE4","title":"Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only by Cesarean Delivery","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-09-10","conditions":"IUD Pain","enrollment":300},{"nctId":"NCT03199820","phase":"PHASE4","title":"Balloon Catheter Versus Propess for Labour Induction","status":"UNKNOWN","sponsor":"St George's, University of London","startDate":"2017-09-22","conditions":"Childbirth Problems, Labor Complication","enrollment":120},{"nctId":"NCT02993432","phase":"NA","title":"High Volume Foleys Increasing Vaginal Birth Pilot Trial","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-12","conditions":"Labour; Induced, Pilot Study, Cervical Ripening","enrollment":130},{"nctId":"NCT03683914","phase":"PHASE4","title":"Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-09-30","conditions":"Office Hysteroscopy","enrollment":102},{"nctId":"NCT02354417","phase":"PHASE1","title":"A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies","status":"TERMINATED","sponsor":"Fate Therapeutics","startDate":"2014-12","conditions":"Hematologic Malignancies","enrollment":3},{"nctId":"NCT02354443","phase":"PHASE1","title":"A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders","status":"TERMINATED","sponsor":"Fate Therapeutics","startDate":"2015-06","conditions":"Metabolic Disorders","enrollment":1},{"nctId":"NCT02620215","phase":"PHASE4","title":"Cervical Ripening Balloon in Induction of Labour at Term","status":"COMPLETED","sponsor":"KK Women's and Children's Hospital","startDate":"2015-11","conditions":"Pregnancy","enrollment":417},{"nctId":"NCT03625518","phase":"EARLY_PHASE1","title":"Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2018-09","conditions":"Fetal Growth Retardation, Induction of Labor Affected Fetus / Newborn","enrollment":280},{"nctId":"NCT03597867","phase":"PHASE3","title":"PGE2 Levels in Patient Treated With NSAIDs","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2018-04-25","conditions":"Ocular Inflammation","enrollment":104},{"nctId":"NCT03489928","phase":"PHASE3","title":"Misoprostol Labour Induction Study","status":"COMPLETED","sponsor":"David Young","startDate":"1999-04-01","conditions":"Induction of Labour, Labour, Induced","enrollment":511},{"nctId":"NCT03390400","phase":"NA","title":"Changes in Prostaglandin Levels in Laser Cataract Surgery (LCS) Subject to Laser Prevalence","status":"UNKNOWN","sponsor":"Rupert Menapace","startDate":"2017-05-29","conditions":"Age Related Cataracts","enrollment":70},{"nctId":"NCT02861079","phase":"PHASE2","title":"Combined Foley Catheter Balloon and PGE2 Vaginal Ovule for Induction of Labor at Term: A Randomized Study","status":"COMPLETED","sponsor":"Zeynep Kamil Maternity and Pediatric Research and Training Hospital","startDate":"2017-08-25","conditions":"Unfavorable Cervix, Cervical Ripening","enrollment":300},{"nctId":"NCT03320187","phase":"PHASE2, PHASE3","title":"Nitroglycerin Skin Patches for Facilitating Cervical Ripening: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-12","conditions":"Induction of Labor Affected Fetus / Newborn","enrollment":100},{"nctId":"NCT00496548","phase":"NA","title":"Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2007-08","conditions":"Crohn's Disease","enrollment":159},{"nctId":"NCT03111602","phase":"NA","title":"Increase of Prostaglandin E2 in Reversal of Ductal Constriction After Dietary Restriction of Polyphenols","status":"COMPLETED","sponsor":"Instituto de Cardiologia do Rio Grande do Sul","startDate":"2011-05","conditions":"Pregnancy Complications","enrollment":75},{"nctId":"NCT01008592","phase":"","title":"The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism","status":"TERMINATED","sponsor":"Wake Forest University","startDate":"2009-04","conditions":"Rhinitis, Urticaria","enrollment":11},{"nctId":"NCT02856724","phase":"PHASE2","title":"Early Amniotomy After Vaginal Prostaglandin E2 for Induction of Labor at Term: a Randomized Clinical Trial","status":"COMPLETED","sponsor":"Zeynep Kamil Maternity and Pediatric Research and Training Hospital","startDate":"2016-08","conditions":"Early Amniotomy, Unfavorable Cervix","enrollment":200},{"nctId":"NCT01527838","phase":"PHASE1","title":"Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit","status":"COMPLETED","sponsor":"Fate Therapeutics","startDate":"2012-01","conditions":"Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease, Chronic Lymphocytic Leukemia (CLL)","enrollment":10},{"nctId":"NCT02801227","phase":"PHASE4","title":"Oxytocin vs. Prostaglandin for Induction of Labor in Primiparas With Prelabor Rupture of Membrane and Low Bishop","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2016-09","conditions":"Premature Rupture of Fetal Membranes","enrollment":68},{"nctId":"NCT02486679","phase":"PHASE4","title":"A Trial of Prostaglandin E2 Tablets Versus Foley Catheter for Labor Induction","status":"UNKNOWN","sponsor":"Wolfson Medical Center","startDate":"2015-07","conditions":"Labor, Induced","enrollment":300},{"nctId":"NCT01765881","phase":"PHASE2","title":"Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2012-09","conditions":"Delivery Uterine","enrollment":1700},{"nctId":"NCT02685085","phase":"PHASE2","title":"Combined Method for Induction of Labor","status":"UNKNOWN","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2016-02","conditions":"Induced Labor","enrollment":300},{"nctId":"NCT02681679","phase":"NA","title":"Topical 0.1% Bromfenac Sodium and Prostaglandin E2 Inhibition in Cataract Surgery","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2014-10","conditions":"Cataract","enrollment":60},{"nctId":"NCT01921374","phase":"NA","title":"Mother-caregivers of Children With Duchenne Muscular Dystrophy","status":"COMPLETED","sponsor":"Monica Levy Andersen","startDate":"2013-08","conditions":"Other Diseases or Conditions","enrollment":60},{"nctId":"NCT02567617","phase":"PHASE2","title":"Polyphenols Supplementation on Prostaglandin E2 in Women - Randomized Clinical Trial","status":"COMPLETED","sponsor":"Instituto de Cardiologia do Rio Grande do Sul","startDate":"2014-05","conditions":"Inflammatory Disorder of the Cardiovascular System","enrollment":26},{"nctId":"NCT00355303","phase":"PHASE4","title":"Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term","status":"COMPLETED","sponsor":"Nilratan Sircar Medical College","startDate":"2006-08","conditions":"Premature Rupture of Membranes at Term","enrollment":932},{"nctId":"NCT02361645","phase":"PHASE3","title":"NSAIDs and PGE2 Levels in Vitrectomy Patients","status":"COMPLETED","sponsor":"Università degli Studi di Brescia","startDate":"2014-03","conditions":"Vitreous Inflammation","enrollment":70},{"nctId":"NCT02154932","phase":"PHASE4","title":"Single Versus Double Dose Intra-vaginal Prostaglandin E2 \"Misoprostol\" Prior Abdominal Myomectomy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2011-01","conditions":"Prostaglandin E2 \"Misoprostol\" Prior Abdominal Myomectomy","enrollment":69},{"nctId":"NCT01635439","phase":"PHASE3","title":"Prostin and Propess in Induction of Labor","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2010-12","conditions":"Labor Pain","enrollment":200},{"nctId":"NCT01863797","phase":"NA","title":"Trial on Early Induction Versus Expectant Management of Nulliparous Women With a Prolonged Latent Phase","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2007-06","conditions":"Nulliparous Women With Prolonged Latent Phase","enrollment":138},{"nctId":"NCT01417923","phase":"PHASE4","title":"The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2011-09","conditions":"Vitamin D Deficiency, Chronic Pain Syndrome, Inflammatory Response","enrollment":80},{"nctId":"NCT01566968","phase":"","title":"Novel Endpoints in Cough Challenge Testing","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2011-01","conditions":"Chronic Obstructive Pulmonary Disease, Asthma, Healthy","enrollment":98},{"nctId":"NCT00815542","phase":"PHASE3","title":"Induction of Labor in Oligohydramnios","status":"UNKNOWN","sponsor":"Meir Medical Center","startDate":"2012-06","conditions":"Cervical Ripening","enrollment":100},{"nctId":"NCT01384812","phase":"NA","title":"Prostaglandin E2 in Migraine Suffers Without Aura.","status":"COMPLETED","sponsor":"Troels Wienecke","startDate":"2010-09","conditions":"\"Migraine-like\" Headache","enrollment":12},{"nctId":"NCT01297790","phase":"","title":"Cough Responses to Tussive Agents in Health and Disease","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2009-11","conditions":"Chronic Obstructive Airway Disease, Asthma, Chronic Cough","enrollment":102},{"nctId":"NCT01021761","phase":"PHASE4","title":"A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification","status":"COMPLETED","sponsor":"Frank A. Bucci, Jr., M.D.","startDate":"2009-10","conditions":"Cataracts","enrollment":126},{"nctId":"NCT00957983","phase":"PHASE1, PHASE2","title":"EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2009-08","conditions":"Headache, Migraine","enrollment":8},{"nctId":"NCT01255839","phase":"PHASE4","title":"The Balloon Project for Birth Induction","status":"COMPLETED","sponsor":"Glostrup University Hospital, Copenhagen","startDate":"2002-12","conditions":"Induction Time, Apgar Score, Admission to Neonatal Unit","enrollment":825},{"nctId":"NCT00006299","phase":"PHASE2","title":"Celebrex for Pain Relief After Oral Surgery","status":"COMPLETED","sponsor":"National Institute of Dental and Craniofacial Research (NIDCR)","startDate":"1999-12","conditions":"Facial Pain","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":848,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["dinoprostone slow release pessary"],"phase":"phase_3","status":"active","brandName":"prostaglandins E2","genericName":"prostaglandins E2","companyName":"Tel-Aviv Sourasky Medical Center","companyId":"tel-aviv-sourasky-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prostaglandin E2 (PGE2) binds to EP prostanoid receptors on cell surfaces to modulate inflammation, immune responses, and tissue remodeling. Used for Graft-versus-host disease (GVHD) or related immune/inflammatory conditions (Phase 3 status suggests clinical development in this area).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}